Best practices for the management of local-regional recurrent chordoma: a position paper by the chordoma global consensus group

التفاصيل البيبلوغرافية
العنوان: Best practices for the management of local-regional recurrent chordoma: a position paper by the chordoma global consensus group
المؤلفون: Gronchi, A., Fossati, P., Akiyama, T., Alapetite, C., Baumann, M., Blay, Jean-Yves, Bolle, S., Boriani, S., Bruzzi, P., Capanna, R., Caraceni, A., Casadei, R., Colia, V., Debus, J., Delaney, T., Desai, A., Dileo, P., Dijkstra, S., Doglietto, F., Flanagan, A., Froelich, S., Gardner, P A., Gelderblom, Hans, Gokaslan, Z L., Haas, R., Heery, C., Hindi, N., Hohenberger, P., Hornicek, F., Imai, R., Jeys, L., Jones, R L., Kasper, Bernd, Kawai, A., Krengli, M., Leithner, A., Logowska, I., Martin Broto, J., Mazzatenta, D., Morosi, C., Nicolai, P., Norum, O J., Patel, S., Penel, Nicolas, Picci, P., Pilotti, S., Radaelli, S., Ricchini, F., Rutkowski, P., Scheipl, S., Sen, C., Tamborini, E., Thornton, K A., Timmermann, B., Torri, V., Tunn, P U., Uhl, M., Yamada, Y., Weber, D C., Vanel, D., Varga, P P., Vleggeert-Lankamp, C La, Casali, Paolo, Sommer, J.
المساهمون: CHU Lille, Université de Lille, Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute Milan, METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694, European Institute of Oncology Milan ESMO, Saitama University, Institut Curie Paris, University of Dresden Medical School, Centre Léon Bérard Lyon, Institut Gustave Roussy IGR, University of Pisa - Università di Pisa, University Medical Center Heidelberg, Massachusetts General Hospital Boston, Queen Elizabeth Hospital, University College London Hospitals UCLH, Universiteit Leiden Leiden, University of Brescia, Cancer Research UK London Research Institute, Hôpital Lariboisière, University of Pittsburgh School of Medicine, Providence University, Netherlands Cancer Institute NKI, National Cancer Institute Bethesda NCI-NIH, Hospital Universitario Virgen del Rocío Sevilla, University of Heidelberg, Medical Faculty, Harvard Medical School Boston HMS, Chiba University Hospital, Queens Elizabeth Hospital Birmingham, Royal Marsden NHS Foundation Trust, National Cancer Center Research Institute Tokyo, Università del Piemonte Orientale - Dipartimento DISIT Italy, Medical University Graz, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology MCMCC, MD Anderson Cancer Center Houston, Evaluation des technologies de santé et des pratiques médicales - ULR 2694 METRICS, University Hospital Graz, New York University Langone Medical Center NYU Langone Medical Center, University of Duisbourg-Essen, Helios Klinikum Erfurt, Memorial Sloane Kettering Cancer Center New York, SwissFEL, Paul Scherrer Institut, Leiden University Medical Center (LUMC)
سنة النشر: 2020
المجموعة: LillOA (Lille Open Archive - Université de Lille)
مصطلحات موضوعية: chemotherapy, chordoma, sarcoma, relapse, radiotherapy, surgery, Mesh:Practice Guidelines as Topic, Mesh:Neoplasm Recurrence, Mesh:Local, Mesh:Chordoma/therapy, Mesh:Humans
الوصف: Chordomas are rare, malignant bone tumors of the skull-base and axial skeleton. Until recently, there was no consensus among experts regarding appropriate clinical management of chordoma, resulting in inconsistent care and suboptimal outcomes for many patients. To address this shortcoming, the European Society of Medical Oncology (ESMO) and the Chordoma Foundation, the global chordoma patient advocacy group, convened a multi-disciplinary group of chordoma specialists to define by consensus evidence-based best practices for the optimal approach to chordoma. In January 2015, the first recommendations of this group were published, covering the management of primary and metastatic chordomas. Additional evidence and further discussion were needed to develop recommendations about the management of local-regional failures. Thus, ESMO and CF convened a second consensus group meeting in November 2015 to address the treatment of locally relapsed chordoma. This meeting involved over 60 specialists from Europe, the United States and Japan with expertise in treatment of patients with chordoma. The consensus achieved during that meeting is the subject of the present publication and complements the recommendations of the first position paper. ; 28
نوع الوثيقة: other/unknown material
وصف الملف: application/octet-stream; application/rdf+xml; charset=utf-8; application/pdf
اللغة: English
تدمد: 28184416
العلاقة: Annals of oncology . official journal of the European Society for Medical Oncology; Ann. Oncol.; http://hdl.handle.net/20.500.12210/17208Test
الإتاحة: https://doi.org/20.500.12210/17208Test
https://hdl.handle.net/20.500.12210/17208Test
حقوق: Attribution-NonCommercial 3.0 United States ; info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.1A0C1E95
قاعدة البيانات: BASE